(Q33415155)

26 July 2017

Efficacy and safety of levofloxacin in patients with nursing and healthcare-associated pneumonia (English)

1 reference

26 July 2017

0 references

1 reference

Kei Yamasaki

1

1 reference

26 July 2017

Kazuhiro Yatera

2

1 reference

26 July 2017

Toshinori Kawanami

3

1 reference

26 July 2017

Yosuke Sasahara

4

1 reference

26 July 2017

Ryosuke Hata

5

1 reference

26 July 2017

Keigo Uchimura

6

1 reference

26 July 2017

Takashi Tachiwada

7

1 reference

26 July 2017

Keisuke Naito

8

1 reference

26 July 2017

Kaori Kato

9

1 reference

26 July 2017

Tsutomu Takaki

10

1 reference

26 July 2017

Ikuko Shimabukuro

11

1 reference

26 July 2017

Tomoko Shiraishi

12

1 reference

26 July 2017

Keishi Oda

13

1 reference

26 July 2017

Kanako Hara

14

1 reference

26 July 2017

Yasuo Chojin

15

1 reference

26 July 2017

Yu Suzuki

16

1 reference

26 July 2017

Kentarou Akata

17

1 reference

26 July 2017

Takaaki Ogoshi

18

1 reference

26 July 2017

Susumu Tokuyama

19

1 reference

26 July 2017

Naoyuki Inoue

20

1 reference

26 July 2017

Shingo Noguchi

21

1 reference

26 July 2017

Chinatsu Nishida

22

1 reference

26 July 2017

Takeshi Orihashi

23

1 reference

26 July 2017

Yugo Yoshida

24

1 reference

26 July 2017

Yukiko Kawanami

25

1 reference

26 July 2017

Yuusuke Taura

26

1 reference

26 July 2017

Hiroshi Ishimoto

27

1 reference

26 July 2017

Hideto Obata

28

1 reference

26 July 2017

Yukikazu Awaya

29

1 reference

26 July 2017

Tohru Tsuda

30

1 reference

26 July 2017

Chiharu Yoshii

31

1 reference

26 July 2017

Hiroshi Mukae

32

1 reference

26 July 2017

language of work or name

Japanese

0 references

publication date

1 February 2014

1 reference

The Journal of Antibiotics

26 July 2017

1 reference

26 July 2017

67

1 reference

26 July 2017

23-32

1 reference

26 July 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1038/ja.2013.81

26 July 2017

0 references

cites work

Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Structure and genetics of circular bacteriocins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Discovery, biosynthesis, and engineering of lantipeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

The radical SAM enzyme AlbA catalyzes thioether bond formation in subtilosin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Lantibiotics: mode of action, biosynthesis and bioengineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Gallidermin: a new lanthionine-containing polypeptide antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Biosynthesis and mode of action of lantibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Isolation, structure elucidation, and synergistic antibacterial activity of a novel two-component lantibiotic lichenicidin from Bacillus licheniformis VK21

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Lantibiotics from Geobacillus thermodenitrificans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Structure revision of the lantibiotic 97518.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Structural characterization of the highly cyclized lantibiotic paenicidin A via a partial desulfurization/reduction strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Entianin, a novel subtilin-like lantibiotic from Bacillus subtilis subsp. spizizenii DSM 15029T with high antimicrobial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Isolation and identification of a Paenibacillus polymyxa strain that coproduces a novel lantibiotic and polymyxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Lacticin 481: in vitro reconstitution of lantibiotic synthetase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

The sequence of the enterococcal cytolysin imparts unusual lanthionine stereochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Dissection of the bridging pattern of bovicin HJ50, a lantibiotic containing a characteristic disulfide bridge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Curvopeptin: a new lanthionine-containing class III lantibiotic and its co-substrate promiscuous synthetase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Synthesis of the lantibiotic lactocin S using peptide cyclizations on solid phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Genome mining for radical SAM protein determinants reveals multiple sactibiotic-like gene clusters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Structure of subtilosin A, an antimicrobial peptide from Bacillus subtilis with unusual posttranslational modifications linking cysteine sulfurs to alpha-carbons of phenylalanine and threonine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Structure of subtilosin A, a cyclic antimicrobial peptide from Bacillus subtilis with unusual sulfur to alpha-carbon cross-links: formation and reduction of alpha-thio-alpha-amino acid derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

The 3D structure of thuricin CD, a two-component bacteriocin with cysteine sulfur to α-carbon cross-links

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Imaging mass spectrometry of intraspecies metabolic exchange revealed the cannibalistic factors of Bacillus subtilis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

The 3D solution structure of thurincin H, a bacteriocin with four sulfur to α-carbon crosslinks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

A Powerful Inhibitory Substance Produced by Group N Streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.81

Pep5: Structure Elucidation of a Large Lantibiotic

21 January 2018

1 reference

9 March 2024

https://opencitations.net/index/api/v1/citations/10.1002/ANIE.198906161

Identifiers

DOI

10.1038/JA.2013.81

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference